Revenue Breakdown
Composition ()
No data
Revenue Streams
Accendra Health Inc (ACH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Diabetes, accounting for 29.6% of total sales, equivalent to $185.79M. Other significant revenue streams include Sleep therapy and Home respiratory therapy. Understanding this composition is critical for investors evaluating how ACH navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Accendra Health Inc maintains a gross margin of 44.29%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 7.38%, while the net margin is -1.03%. These profitability ratios, combined with a Return on Equity (ROE) of -198.35%, provide a clear picture of how effectively ACH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ACH competes directly with industry leaders such as LUCD and SMTI. With a market capitalization of $216.73M, it holds a significant position in the sector. When comparing efficiency, ACH's gross margin of 44.29% stands against LUCD's -37.74% and SMTI's 90.97%. Such benchmarking helps identify whether Accendra Health Inc is trading at a premium or discount relative to its financial performance.
